Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-metastatic Patients With Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04046445
What this trial is testing

Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal CancerMSSStage IV Colon Cancer+3 more
Amal Therapeutics 96
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Not applicableStudy completedNCT02673710
What this trial is testing

Assess the Impact of Sarcopenia on the Outcomes of Colorectal Cancer Patients Treated With Chemotherapy Combined With Bevacizumab

Who this might be right for
Metastatic Colorectal Cancer
Hoffmann-La Roche 200
Testing effectiveness (Phase 2)Ended earlyNCT01759238
What this trial is testing

Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer

Who this might be right for
Colorectal CancerMetastases
Universitätsklinikum Hamburg-Eppendorf 1
Testing effectiveness (Phase 2)Study completedNCT03565003
What this trial is testing

A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China

Who this might be right for
Non-small Cell Lung CancerHead and Neck CancerEsophageal Cancer+1 more
Jacobio Pharmaceuticals Co., Ltd. 126
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Ended earlyNCT04234113
What this trial is testing

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Thyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more
SOTIO Biotech AG 115
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Early research (Phase 1)Ended earlyNCT01238965
What this trial is testing

Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+1 more
University of Southern California 7
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Not applicableStudy completedNCT03665506
What this trial is testing

Trifluridin/tipirACil in MeTastatIc Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Servier 315
Early research (Phase 1)Study completedNCT01451632
What this trial is testing

A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers

Who this might be right for
Colorectal CancerSquamous Cell Head and Neck CancerNon-small Cell Lung Cancer+2 more
Merrimack Pharmaceuticals 48
Testing effectiveness (Phase 2)Study completedNCT01674309
What this trial is testing

First Line Treatment by FOLFIRINOX for Patients With a Rectum Cancer With Synchronous Non Resectable Metastasis

Who this might be right for
Adenocarcinoma of Rectum
Federation Francophone de Cancerologie Digestive 65
Early research (Phase 1)UnknownNCT00090727
What this trial is testing

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Solid MalignanciesNon-Hodgkin's Lymphoma
Novacea 45
Early research (Phase 1)Study completedNCT00514306
What this trial is testing

Study of Intermittent OSI-906 Dosing

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 79
Early research (Phase 1)Study completedNCT01124630
What this trial is testing

Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments

Who this might be right for
Metastatic Colorectal Cancer
Daiichi Sankyo 21
Early research (Phase 1)Ended earlyNCT05631574
What this trial is testing

Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer

Who this might be right for
Non Small Cell Lung CancerPancreatic CancerColorectal Cancer+14 more
Biomea Fusion Inc. 13
Next Page